BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 16411214)

  • 1. Pathologic findings from the Breast Cancer Surveillance Consortium: population-based outcomes in women undergoing biopsy after screening mammography.
    Weaver DL; Rosenberg RD; Barlow WE; Ichikawa L; Carney PA; Kerlikowske K; Buist DS; Geller BM; Key CR; Maygarden SJ; Ballard-Barbash R
    Cancer; 2006 Feb; 106(4):732-42. PubMed ID: 16411214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in breast biopsy pathology diagnoses among women undergoing mammography in the United States: a report from the Breast Cancer Surveillance Consortium.
    Allison KH; Abraham LA; Weaver DL; Tosteson AN; Nelson HD; Onega T; Geller BM; Kerlikowske K; Carney PA; Ichikawa LE; Buist DS; Elmore JG
    Cancer; 2015 May; 121(9):1369-78. PubMed ID: 25603785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term outcomes of screening mammography using computer-aided detection: a population-based study of medicare enrollees.
    Fenton JJ; Xing G; Elmore JG; Bang H; Chen SL; Lindfors KK; Baldwin LM
    Ann Intern Med; 2013 Apr; 158(8):580-7. PubMed ID: 23588746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of ductal carcinoma in situ in women undergoing screening mammography.
    Ernster VL; Ballard-Barbash R; Barlow WE; Zheng Y; Weaver DL; Cutter G; Yankaskas BC; Rosenberg R; Carney PA; Kerlikowske K; Taplin SH; Urban N; Geller BM
    J Natl Cancer Inst; 2002 Oct; 94(20):1546-54. PubMed ID: 12381707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model.
    Gangnon RE; Sprague BL; Stout NK; Alagoz O; Weedon-Fekjær H; Holford TR; Trentham-Dietz A
    Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):905-12. PubMed ID: 25787716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast Biopsy Intensity and Findings Following Breast Cancer Screening in Women With and Without a Personal History of Breast Cancer.
    Buist DSM; Abraham L; Lee CI; Lee JM; Lehman C; O'Meara ES; Stout NK; Henderson LM; Hill D; Wernli KJ; Haas JS; Tosteson ANA; Kerlikowske K; Onega T;
    JAMA Intern Med; 2018 Apr; 178(4):458-468. PubMed ID: 29435556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First epidemiological analysis of breast cancer incidence and tumor characteristics after implementation of population-based digital mammography screening.
    Weigel S; Batzler WU; Decker T; Hense HW; Heindel W
    Rofo; 2009 Dec; 181(12):1144-50. PubMed ID: 19859859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
    Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
    Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammography surveillance following breast cancer.
    Geller BM; Kerlikowske K; Carney PA; Abraham LA; Yankaskas BC; Taplin SH; Ballard-Barbash R; Dignan MB; Rosenberg R; Urban N; Barlow WE
    Breast Cancer Res Treat; 2003 Sep; 81(2):107-15. PubMed ID: 14572153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI of occult breast carcinoma in a high-risk population.
    Morris EA; Liberman L; Ballon DJ; Robson M; Abramson AF; Heerdt A; Dershaw DD
    AJR Am J Roentgenol; 2003 Sep; 181(3):619-26. PubMed ID: 12933450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance and staging of nonpalpable carcinomas of the breast.
    Schwartz GF; Feig SA; Patchefsky AS
    Surg Gynecol Obstet; 1988 Jan; 166(1):6-10. PubMed ID: 2827328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy.
    Park HS; Park S; Cho J; Park JM; Kim SI; Park BW
    J Surg Oncol; 2013 Mar; 107(4):388-92. PubMed ID: 23007901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgeon-read screening mammography: an analysis of 11,948 examinations.
    Apffelstaedt JP; Steenkamp V; Baatjes KJ
    Ann Surg Oncol; 2010 Oct; 17 Suppl 3():249-54. PubMed ID: 20853042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biennial versus annual mammography and the risk of late-stage breast cancer.
    White E; Miglioretti DL; Yankaskas BC; Geller BM; Rosenberg RD; Kerlikowske K; Saba L; Vacek PM; Carney PA; Buist DS; Oestreicher N; Barlow W; Ballard-Barbash R; Taplin SH
    J Natl Cancer Inst; 2004 Dec; 96(24):1832-9. PubMed ID: 15601639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors Associated With Rates of False-Positive and False-Negative Results From Digital Mammography Screening: An Analysis of Registry Data.
    Nelson HD; O'Meara ES; Kerlikowske K; Balch S; Miglioretti D
    Ann Intern Med; 2016 Feb; 164(4):226-35. PubMed ID: 26756902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of invasive breast cancer and lymph node involvement in ductal carcinoma in situ initially diagnosed by vacuum-assisted breast biopsy: experience of 733 cases.
    Trentin C; Dominelli V; Maisonneuve P; Menna S; Bazolli B; Luini A; Cassano E
    Breast; 2012 Oct; 21(5):635-40. PubMed ID: 22795363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Visibility in ultrasonography as the strongest invasion predictor in ductal carcinoma in situ in a retrospective study].
    Vrtelová P; Coufal O; Pavlík T; Bazout M; Fait V
    Klin Onkol; 2009; 22(6):278-83. PubMed ID: 20099746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of the presence of invasive disease from the measurement of extent of malignant microcalcification on mammography and ductal carcinoma in situ grade at core biopsy.
    O'Flynn EA; Morel JC; Gonzalez J; Dutt N; Evans D; Wasan R; Michell MJ
    Clin Radiol; 2009 Feb; 64(2):178-83. PubMed ID: 19103348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy.
    Mittendorf EA; Arciero CA; Gutchell V; Hooke J; Shriver CD
    Curr Surg; 2005; 62(2):253-7. PubMed ID: 15796952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.